Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury?
about
Human miR-221/222 in Physiological and Atherosclerotic Vascular RemodelingThe role of RNA interference in the developmental separation of blood and lymphatic vasculatureSmooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function.Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function.Deletion of Dicer in smooth muscle affects voiding pattern and reduces detrusor contractility and neuroeffector transmissionMicroRNA miR145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cellsMechanical stretch suppresses microRNA-145 expression by activating extracellular signal-regulated kinase 1/2 and upregulating angiotensin-converting enzyme to alter vascular smooth muscle cell phenotypePlasma Levels of microRNA-145 Are Associated with Severity of Coronary Artery Disease.MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndromeRegulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504Phenotypic switching of vascular smooth muscle cells in the 'normal region' of aorta from atherosclerosis patients is regulated by miR-145MicroRNA regulation of smooth muscle gene expression and phenotype.The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?Stretch-dependent smooth muscle differentiation in the portal vein-role of actin polymerization, calcium signaling, and microRNAs.Vascular smooth muscle cell in atherosclerosis.Modulation of miRNAs in Pulmonary HypertensionAn overview of potential molecular mechanisms involved in VSMC phenotypic modulation.Nonclinical safety biomarkers of drug-induced vascular injury: current status and blueprint for the future.MicroRNAs-control of essential genes: Implications for pulmonary vascular disease.Induction of angiotensin-converting enzyme after miR-143/145 deletion is critical for impaired smooth muscle contractility.Macrophage deficiency of miR-21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis.MYOSLID Is a Novel Serum Response Factor-Dependent Long Noncoding RNA That Amplifies the Vascular Smooth Muscle Differentiation Program.Regulation of vascular smooth muscle mechanotransduction by microRNAs and L-type calcium channels.MicroRNAs are essential for stretch-induced vascular smooth muscle contractile differentiation via microRNA (miR)-145-dependent expression of L-type calcium channels.Modulation of smooth muscle cell phenotype: the other side of the story.Spontaneous activity and stretch-induced contractile differentiation are reduced in vascular smooth muscle of miR-143/145 knockout mice.Selective expression of TSPAN2 in vascular smooth muscle is independently regulated by TGF-β1/SMAD and myocardin/serum response factor.MicroRNA Regulation of Smooth Muscle Phenotype.miRNA-22 is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation.Enlightening the Association between Bicuspid Aortic Valve and Aortopathy.Angiotensin II prevents calcification in vascular smooth muscle cells by enhancing magnesium influx.Therapeutic Potential of Modulating microRNAs in Atherosclerotic Vascular Disease.MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/-mice.MicroRNAs and cardiovascular diseases
P2860
Q26801898-C1656A66-9F34-4193-9106-2BB7D9673285Q33615449-C3F31C0F-E65C-4794-B400-595957087413Q33883484-7F447CFC-B8B4-4F84-9723-67E3B2A76B40Q34001116-3CE25CA3-5DC2-42C6-BBA8-A5FEC71CD1C9Q34256861-F86DB74E-DCD6-43B1-83A7-0269C5F3B32AQ34987622-D2F4F9DD-FA90-4F81-99E4-D089495BC5E8Q35172003-1D3DED7D-4696-41E8-804F-0D0FD6444E9DQ35566567-901EA1DB-5FC9-4CFD-818F-71099B313EF4Q36773823-0167CECB-7982-4E74-AB00-83B4C53F3170Q36849525-76671BA5-8BDA-4C1E-A43E-8849E681E106Q36942350-CF8F7B0A-D029-4F2B-BD6E-5A55EE062C4DQ37580458-57376990-2254-47D5-80EE-AFBFD54FDE93Q38103313-CEBD5564-B2C3-4149-A016-B87425A8D2DBQ38163112-E39A7DC2-2786-4AB1-9511-7C57094DFA1EQ38353932-6C28636B-4358-4B0F-A26F-3C1556FD905AQ38414863-5E6394A0-1EA9-4016-AF34-379EEBBB840AQ38680594-F2C8C7F3-6C67-4CEA-B98E-8A0C4F481386Q39201920-8E7DDB57-A763-42D4-82CE-E6EDAD1AE091Q39385085-07E80C95-CEB5-45C4-BD6E-526FAB0CD8D9Q40036253-8A353D19-5C0F-4CE1-B3D0-443AAE23F321Q41601003-8E9D553E-2906-42F9-949D-8D6AFCAB3563Q41633123-152C6372-D18A-4E64-AFA6-66EE059D9BF2Q41893998-8A52A1BD-56D4-4C7B-8CF7-D981BF6B7049Q42183020-BAC4D1C2-2678-486A-8BEC-D1B421744CA9Q42324593-EFEBFF7F-8B7B-4E4A-9FF0-A3DD732A9EF0Q42478016-3AA8A805-6D8B-44E3-8587-6EBE5C20A1E2Q42775877-51050BB5-7344-4090-B4CF-0DBB889E2B2AQ42936326-84E0FA16-662B-4718-B3DF-15C4687CD9C3Q47287722-E7E838D9-6FC7-4D1E-9B94-4DD4BEB851A6Q52718355-B2905C34-189C-4F99-8D23-A1661CE59C2EQ53381329-241E66A8-B10F-4F05-8A83-1593C8FDADABQ55543105-C1478ECA-6125-4EED-BB34-D934B0E25146Q55713349-1E7B822B-D475-4ABC-8E4A-B8BDE2C6DBD6Q59104729-8B6181BF-7943-42FF-B3B5-3DD5CAA359BB
P2860
Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury?
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Can microRNAs control vascular ...... on and the response to injury?
@ast
Can microRNAs control vascular ...... on and the response to injury?
@en
type
label
Can microRNAs control vascular ...... on and the response to injury?
@ast
Can microRNAs control vascular ...... on and the response to injury?
@en
prefLabel
Can microRNAs control vascular ...... on and the response to injury?
@ast
Can microRNAs control vascular ...... on and the response to injury?
@en
P2860
P1476
Can microRNAs control vascular ...... on and the response to injury?
@en
P2093
William C Sessa
P2860
P304
P356
10.1152/PHYSIOLGENOMICS.00146.2010
P577
2010-09-14T00:00:00Z